Worth reading
40Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
935000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock options (new share acquisition rights)
Who receives how much
935,000 shares of the Company's common stock (9,350 share acquisition rights, with 100 shares per share acquisition right)
Directors of the Company (excluding directors who are Audit and Supervisory Committee members)3 / 510,000 shares
Employees of the Company5 / 135,000 shares
Employees of the Company's subsidiaries12 / 290,000 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Terms of the stock acquisition rights
Exercise price
¥6,100 per share acquisition right, or ¥61 per share. Although a stock price-based calculation method is described, the presence or absence of an adjustment provision and the adjustment floor are not disclosed.
Number of Stock Acquisition Rights
Total issued: 9,350 share acquisition rights; unexercised balance: not disclosed
Categories and Number of Persons Covered
3 Company directors, 5,100 share acquisition rights (510,000 shares); 5 Company employees, 1,350 share acquisition rights (135,000 shares); 12 employees of the Company's subsidiaries, 2,900 share acquisition rights (290,000 shares)
Basis for determining the amount to be paid
The higher of (i) the average closing price on each trading day in the month preceding the month that includes the issuance date (14 April 2026), multiplied by 1.05, and (ii) the closing price on the allotment date. Amounts below ¥1 are rounded up.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock options (new share acquisition rights) |
| Number of shares to be issued or disposed of | 935,000 shares of the Company's common stock (9,350 share acquisition rights, with 100 shares per share acquisition right) |
| Intended allottee | Category Directors of the Company (excluding directors who are Audit and Supervisory Committee members) / Number of Employees 3 / Number of stock acquisition rights 5,100 JDRs / Number of shares 510,000 shares, Category Employees of the Company / Number of Employees 5 / Number of stock acquisition rights 1,350 share acquisition rights / Number of shares 135,000 shares, Category Employees of the Company's subsidiaries / Number of Employees 12 / Number of stock acquisition rights 2,900 share acquisition rights / Number of shares 290,000 shares |
| Basis for determining the amount to be paid | The higher of (i) the average closing price on each trading day in the month preceding the month that includes the issuance date (14 April 2026), multiplied by 1.05, and (ii) the closing price on the allotment date. Amounts below ¥1 are rounded up. |
| Exercise price | ¥6,100 per share acquisition right, or ¥61 per share. Although a stock price-based calculation method is described, the presence or absence of an adjustment provision and the adjustment floor are not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 9,350 share acquisition rights; unexercised balance: not disclosed |
| Categories and Number of Persons Covered | 3 Company directors, 5,100 share acquisition rights (510,000 shares); 5 Company employees, 1,350 share acquisition rights (135,000 shares); 12 employees of the Company's subsidiaries, 2,900 share acquisition rights (290,000 shares) |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Previously undecided matters relating to the issuance of the 18th Series of Share Acquisition Rights to the Company's directors, employees and employees of its subsidiaries have been finalized.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.